Therapy News and Research

RSS

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

"Beaumont researchers have invented a new mode of proton therapy for lung cancer," said Peyman Kabolizadeh, M.D., Ph.D., clinical director, Beaumont Proton Therapy Center in Royal Oak.

17 May 2018

Researcher develops small molecules that inhibit derailment of gene expression in cancer

Not everyone person who has a "cancer gene" will inevitably develop this disease in their lifetime. Thanks to a new area of research called epigenetics, we now know that many genes are only read under certain circumstances.

17 May 2018

ECDC whole genome sequencing study helps understand prevalence of drug-resistant gonorrhea

Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer.

16 May 2018

Musician Huey Lewis's struggle shines spotlight on Ménière's disease

The recent news revealing musician Huey Lewis's struggles with Ménière's disease has shined a spotlight on the neurological disorder. The symptoms, which include unpredictable bouts of dizziness, hearing loss and ringing in the ears, may get progressively worse over time and can greatly interfere with work, driving and daily activities.

16 May 2018

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.

16 May 2018

FDA allows KU Medical Center to begin clinical trial of novel cellular therapy for HR/SR aGvHD

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute graft-versus-host disease (HR/SR aGvHD).

16 May 2018

Combination therapies targeting different cell types may be effective at treating colon cancer

Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed.

16 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Record numbers of American veterans diagnosed with non-aggressive prostate cancer are heeding the advice of international medical experts and opting out of immediate surgery or radiation to treat their cancer.

16 May 2018

MDMA appears to help in treating PTSD patients

When lasting trauma is caused by callous acts of violence, the key to recovery can be making meaning out of meaninglessness.

16 May 2018

Post-menopausal Conversations: Why You Should Talk to Your Clinician

Many post-menopausal women shy away from discussing their sexual health with their physician, often because they believe it is a natural part of life and they should suffer. Dr. Mickey Karram wants to change that, by encouraging women to talk to their physician about the treatments available to them.

16 May 2018

Study finds distinct exhausted T cells that could have implications for fighting different diseases

The battle between the human immune system and long-term, persisting infections and other chronic diseases such as cancer results in a prolonged stalemate

16 May 2018

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

The most severe allergic reaction, anaphylaxis, is the result of an inappropriate immune reaction following the introduction of a usually harmless antigen into the body.

16 May 2018

Cleveland Clinic researcher wins NCI grant to delve into cancer genetics and radiation effectiveness

Can the genetic makeup of their cancers predict how patients with lung cancer will respond to radiation therapy? And can this information be used to advance a genetically guided strategy for patients with these tumors? Cleveland Clinic researcher and radiation oncologist Mohamed Abazeed, M.D., Ph.D., has been awarded a $2 million grant from the National Cancer Institute (NCI) to delve into those and other related questions.

15 May 2018

Study: Gadolinium deposition in brain not associated with dosage

Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.

15 May 2018

Therapy News and Research

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

Researcher develops small molecules that inhibit derailment of gene expression in cancer

ECDC whole genome sequencing study helps understand prevalence of drug-resistant gonorrhea

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Musician Huey Lewis's struggle shines spotlight on Ménière's disease

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

FDA allows KU Medical Center to begin clinical trial of novel cellular therapy for HR/SR aGvHD

Combination therapies targeting different cell types may be effective at treating colon cancer

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

MDMA appears to help in treating PTSD patients

Post-menopausal Conversations: Why You Should Talk to Your Clinician

Study finds distinct exhausted T cells that could have implications for fighting different diseases

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

Cleveland Clinic researcher wins NCI grant to delve into cancer genetics and radiation effectiveness

Study: Gadolinium deposition in brain not associated with dosage

Lash Group introduces latest solution for electronic benefit verification

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Scientists examine vitamin D levels in children with non-alcoholic fatty liver disease

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News